Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 190

Emailed: 0

PDF Downloaded: 558


Malik, Khajuria, Khattri, Singh, and Veeresh VG: Prevalence of Gestational thrombocytopenia in five cities of India: A cross sectional descriptive study


Introduction

A common haematological disease is thrombocytopenia, which is defined as a platelet count of fewer than 150,000 per litre.1, 2, 3, 4 The most prevalent haematological disorder in pregnancy, it is second only to anaemia.5, 6, 7

Gestational thrombocytopenia is condition with platelets count less than 50000 in a pregnant women, the incidence is asymptomatic and occurs in second half of pregnancy, 8, 9 in the absence of history of thrombocytopenia the of platelets count returns to normal level within two months of postpartum. 10, 11 The gestational thrombocytopenia is not associated with maternal or fetal risk. 12, 13, 14, 15 Even after less risk for mother and child the gestational thrombocytopenia can be serious issue and can cause potential problems5 to mother during labor and postpartum period, hence the prevalence is essential to understand so the present study aim to learn the prevalence of gestational thrombocytopenia in India.

Objectives

The present study is aimed to assess the prevalence of gestational thrombocytopenia in various cities of India.

Materials and Methods

A cross sectional designed to assess the prevalence of gestational thrombocytopenia in India for a period of 6 months from January 2022 to June 2022. A total of 3952 women were investigated from various cities in India like Lucknow, Panipat, Sonipat, Gohana, Delhi. Blood sample was withdrawn. Platelet count was performed using manual method and automated hematology method.

Inclusion criteria

  1. All pregnant women were included in the study

Exclusion criteria

  1. Pregnant or non- pregnant women having diabetes or thrombo-embolic disorders were excluded from the study

Results

The present study designed to assess the prevalence of gestational thrombocytopenia. The following are the findings of the study.

Figure 1

Arrow 1 indicates Giant thrombocyte, Arrow 2 indicates normal thrombocyte and arrow

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/3d8ba4eb-4754-4f00-8d9b-6ba3feb3957eimage1.png
Table 1

Describes the distribution of the gestational thrombocytopenia cases at various cities under study.

S.No.

City

Number of samples

Number of gestational thrombocytopenia

Percentage

1

Lucknow

645

28

4.3

2

Panipat

978

39

3.9

3

Sonipat

967

36

3.7

4

Gohana

597

15

2.5

5

Delhi

765

19

2.4

Total

3952

137

3.4

Table 1 describes the distribution of gestational thrombocytopenia cases at various selected cities ofIndia, in Lucknow total 645 samples were collected of them 28 samples, in Panipat total 978 samples were collected 39 samples, in Sonipat total 967 samples were collected of them 36 samples, in Gohana total 597 samples were collected of them 15 samples and in Delhi total 765 samples were collected of them 19 samples were gestational thrombocytopenia respectively.

The study also found that prevalence of gestational thrombocytopenia in total samples of 3952, at Lucknow is 4.3%, Panipat is 3.9%, Sonipat is 3.7%, Gohana is 2.5%, Delhi is 2.4% respectively and total prevalence of gestational thrombocytopenia represented in pie diagram. The study also found that prevalence of gestational thrombocytopenia is 3.4%.

Table 2

hows demographic and obstetrical profile

Parameters

No. of cases

%

Gestational age (weeks)

30-33

37

27

34-36

30

21

37-40

70

51

Severity of thrombocytopenia

Mild

35

25.5

Moderate

22

16

Severe

80

58.7

Table 2 shows demographic and obstetrical profile. During the study period records revealed that 37 women (27%) belonged to gestational age of 30-33 weeks, 30 women (21%) belonged to gestational age of 34-36 weeks and 70 women (51%) belonged to gestational age of 37-40 weeks. Thirty-five (25.5%) cases had mild thrombocytopenia, 22 women (16%) had moderate, and 80 women (58.7%) had severe thrombocytopenia.

Discussion

The present study aimed to study the prevalence of the gestational thrombocytopenia in various cities of India. The study conducted for a period of 6 month from January 2022 to June 2022 collected 3952 pregnant samples of which 137 samples showed gestational thrombocytopenia.

The present study designed to assess the distribution of the prevalence of the gestational thrombocytopenia found that the prevalence at Lucknow is 4.3%, Panipat is 3.9%, sonipatis 3.7%, Gohana is 2.5%, Delhi is 2.4% and the overall prevalence of gestational thrombocytopenia is 3.4%, these findings were like the study. 16, 17, 18 Furthermore, Records for the research period showed that 70 women (51%) were gestational age 37–40 weeks, whereas 37 women (27%) were in the 30-33 week, 34–36 week, and 37–40 week ranges. In 35 cases (25.5%), the thrombocytopenia was mild, in 22 cases (16%), it was moderate, and in 80 cases (58.7%), it was severe.

Conclusion

Gestational thrombocytopenia can cause due to number of causes, the knowledge of prevalence of gestational thrombocytopenia can prevent the complication related to decreased platelets, bleeding is the major complication can be life threatening and demanding emergency care, the present study found that prevalence of gestational thrombocytopenia as 3.4% which is evident by other studies. This prevalent gives relevant information to control and prevent the complications, disorder and manage mother and newborn care and well-being

Conflict of Interest

There are no conflicts of interest in this article.

Source of Funding

None.

References

1 

K Haile S Kebede T Abera A Timerga A Mose Thrombocytopenia Among Pregnant Women in Southwest Ethiopia: Burden, Severity, and PredictorsJ Blood Med2022132758210.2147/JBM.S365812

2 

M Wodaje N Tadele H Lijaemiro A Demtse D Birhanu H Tadele Prevalence of Thrombocytopenia and Its Associated Factors Among Neonates Admitted in Neonatal Intensive Care Unit of Addis Ababa Public Hospitals, Ethiopia 2020/21(Cross Sectional Study)Res Square202210.21203/rs.3.rs-1431306/v1

3 

BM Odhiambo Prevalence, Risk Factors and Timing of Occurrence of Stillbirths Among Patients With Hypertensive Disorders of Pregnancy at Kenyatta National Hospital in 2018-2019; a Cross-sectional Study (Doctoral dissertation, University of Nairobi)https://shorturl.at/ilCS5

4 

Z Iqbal S S Memon J D Maheshwari U Zafar N Lathiya SS Khalid Comparison of Clinical and Biological/Laboratory Findings of Malaria and Dengue Infection in Karachi. A Cross Sectional SurveyPak J Med Health Sci2022169933

5 

S Getawa Z Getaneh M Melku Thrombocytopenia among pregnant women in Africa: a systematic review and meta-analysisThe Pan African Med J20224133410.11604/pamj.2022.41.334.30175

6 

SS Kebede A Yalew T Yesuf M Melku GM Bambo B Woldu The magnitude and associated factors of immune hemolytic anemia among human immuno deficiency virus infected adults attending University of Gondar comprehensive specialized hospital north west Ethiopia 2021 GC, cross sectional study designPLoS One20221710e027446410.1371/journal.pone.0274464

7 

F Boehlen P Hohlfeld P Extermann TV Perneger P De Moerloose Platelet count at term pregnancy: a reappraisal of the thresholdObstet Gynecol20009512933

8 

S Nisha D Amita S Uma AK Tripathi S Pushplata Prevalence and characterization of thrombocytopenia in pregnancy in Indian womenIndian J Hematol Blood Transfus20122827781

9 

RA Fay AO Hughes NT Farron Platelets in pregnancy: hyperdestruction in pregnancyObstet Gynecol198361223840

10 

E Verdy V Bessous M Dreyfus C Kaplan G Tchernia S Uzan Longitudinal analysis of platelet count and volume in normal pregnancyThromb Haemost19977748067

11 

D Provan R Stasi AC Newland V S Blanchette P Bolton-Maggs JB Bussel International consensus report on the investigation and management of primary immune thrombocytopeniaBlood201011521688610.1182/blood-2009-06-225565

12 

T Gernsheimer A H James R Stasi How I treat thrombocytopenia in pregnancyBlood20131211384710.1182/blood-2012-08-448944American Society of Hematology

13 

RF Burrows JG Kelton Fetal thrombocytopenia and its relation to maternal thrombocytopeniaN Engl J Med19933292014636

14 

N Nathan I Sol A Vincelot D Collet P Granchamp E David Is a biological assessment necessary to realize an obstetrical epidural anaesthesia in a patient whose interrogation and clinical examination are strictly normal?Ann Fr Anesth Reanim2007267-870510

15 

RS Schwartz Immune thrombocytopenic purpura-from agony to agonistN Engl J Med200735722229930110.1056/NEJMe0707126

16 

JP Gisbert Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feedingInflamm Bowel Dis20101658819510.1002/ibd.21154

17 

C Nefmert M A Crowther The American Society of Hematology 2011 evidence-based practice^ miideline for immune thrombocytopeniaBlood20111174190207American Society of Hematology

18 

H Ebrahim B Kebede M Tilahun H Debash H Bisetegn M Tesfaye Magnitude and Associated Factors of Thrombocytopenia among Pregnant Women Attending Antenatal Care Clinics at Dessie Comprehensive Specialized Hospital, Northeast EthiopiaClin Appl Thrombosis/Hemostasis202210.1177/10760296221097379



jats-html.xsl

© 2023 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)